Synthesis, in vitro urease inhibitory activity, and molecular docking studies of (perfluorophenyl)hydrazone derivatives
Abstract A series of (perfluorophenyl)hydrazone derivatives 1–27 were synthesized by the condensation reaction of (perfluorophenyl)hydrazine with a variety of benzaldehydes. Compounds were structurally characterized by various spectroscopic techniques. All compounds were screened for their urease inhibitory activity which revealed that most of the analogs exhibited significant urease inhibitory activity in the range of $ IC_{50} $ = 14.09 ± 0.23–78.69 ± 1.56 µM as compare to the standard thiourea ($ IC_{50} $ = 21.10 ± 0.31 µM). Amongst active compounds, derivatives 2 ($ IC_{50} $ = 14.23 ± 0.21 µM), 5 ($ IC_{50} $ = 16.78 ± 0.33 µM), 7 ($ IC_{50} $ = 15.59 ± 0.60 µM), 9 ($ IC_{50} $ = 20.18 ± 0.78 µM), 10 ($ IC_{50} $ = 16.13 ± 0.93 µM), and 11 ($ IC_{50} $ = 14.09 ± 0.23 µM) showed potent inhibitory activity better than the standard thiourea. A limited structure-activity relationship (SAR) was established by rationalized the effect of different groups on the inhibitory potential. Molecular docking study was performed to understand the binding modes of active analogs into the active site of urease enzyme..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
---|---|
Enthalten in: |
Medicinal chemistry research - 28(2019), 6 vom: 16. Apr., Seite 873-883 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Khan, Momin [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
(Perfluorophenyl)hydrazones |
---|
Anmerkungen: |
© Springer Science+Business Media, LLC, part of Springer Nature 2019 |
---|
doi: |
10.1007/s00044-019-02341-5 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC2096116481 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | OLC2096116481 | ||
003 | DE-627 | ||
005 | 20230331233042.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230331s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00044-019-02341-5 |2 doi | |
035 | |a (DE-627)OLC2096116481 | ||
035 | |a (DE-He213)s00044-019-02341-5-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 540 |a 610 |q VZ |
084 | |a PHARM |q DE-84 |2 fid | ||
100 | 1 | |a Khan, Momin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Synthesis, in vitro urease inhibitory activity, and molecular docking studies of (perfluorophenyl)hydrazone derivatives |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © Springer Science+Business Media, LLC, part of Springer Nature 2019 | ||
520 | |a Abstract A series of (perfluorophenyl)hydrazone derivatives 1–27 were synthesized by the condensation reaction of (perfluorophenyl)hydrazine with a variety of benzaldehydes. Compounds were structurally characterized by various spectroscopic techniques. All compounds were screened for their urease inhibitory activity which revealed that most of the analogs exhibited significant urease inhibitory activity in the range of $ IC_{50} $ = 14.09 ± 0.23–78.69 ± 1.56 µM as compare to the standard thiourea ($ IC_{50} $ = 21.10 ± 0.31 µM). Amongst active compounds, derivatives 2 ($ IC_{50} $ = 14.23 ± 0.21 µM), 5 ($ IC_{50} $ = 16.78 ± 0.33 µM), 7 ($ IC_{50} $ = 15.59 ± 0.60 µM), 9 ($ IC_{50} $ = 20.18 ± 0.78 µM), 10 ($ IC_{50} $ = 16.13 ± 0.93 µM), and 11 ($ IC_{50} $ = 14.09 ± 0.23 µM) showed potent inhibitory activity better than the standard thiourea. A limited structure-activity relationship (SAR) was established by rationalized the effect of different groups on the inhibitory potential. Molecular docking study was performed to understand the binding modes of active analogs into the active site of urease enzyme. | ||
650 | 4 | |a Synthesis | |
650 | 4 | |a (Perfluorophenyl)hydrazones | |
650 | 4 | |a Schiff bases | |
650 | 4 | |a Urease inhibition | |
650 | 4 | |a Structure-activity relationship | |
650 | 4 | |a Molecular docking | |
700 | 1 | |a Ahad, Ghulam |4 aut | |
700 | 1 | |a Manaf, Abdul |4 aut | |
700 | 1 | |a Naz, Reshma |4 aut | |
700 | 1 | |a Hussain, Syed Roohul |4 aut | |
700 | 1 | |a Deeba, Farah |4 aut | |
700 | 1 | |a Shah, Sana |4 aut | |
700 | 1 | |a Khan, Ajmal |4 aut | |
700 | 1 | |a Ali, Majid |4 aut | |
700 | 1 | |a Zaman, Khair |4 aut | |
700 | 1 | |a Zafar, Salman |4 aut | |
700 | 1 | |a Salar, Uzma |4 aut | |
700 | 1 | |a Hameed, Abdul |4 aut | |
700 | 1 | |a Khan, Khalid Mohammed |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Medicinal chemistry research |d Springer US, 1991 |g 28(2019), 6 vom: 16. Apr., Seite 873-883 |h Online-Ressource |w (DE-627)490223427 |w (DE-600)2191978-1 |w (DE-576)262493225 |x 1554-8120 |7 nnns |
773 | 1 | 8 | |g volume:28 |g year:2019 |g number:6 |g day:16 |g month:04 |g pages:873-883 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00044-019-02341-5 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OPC-PHA | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_32 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_90 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_100 | ||
912 | |a GBV_ILN_101 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_120 | ||
912 | |a GBV_ILN_138 | ||
912 | |a GBV_ILN_150 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_152 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_187 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_370 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_636 | ||
912 | |a GBV_ILN_702 | ||
912 | |a GBV_ILN_2001 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2004 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a GBV_ILN_2007 | ||
912 | |a GBV_ILN_2008 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2015 | ||
912 | |a GBV_ILN_2020 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a GBV_ILN_2025 | ||
912 | |a GBV_ILN_2026 | ||
912 | |a GBV_ILN_2027 | ||
912 | |a GBV_ILN_2031 | ||
912 | |a GBV_ILN_2034 | ||
912 | |a GBV_ILN_2037 | ||
912 | |a GBV_ILN_2038 | ||
912 | |a GBV_ILN_2039 | ||
912 | |a GBV_ILN_2044 | ||
912 | |a GBV_ILN_2048 | ||
912 | |a GBV_ILN_2049 | ||
912 | |a GBV_ILN_2055 | ||
912 | |a GBV_ILN_2057 | ||
912 | |a GBV_ILN_2059 | ||
912 | |a GBV_ILN_2061 | ||
912 | |a GBV_ILN_2064 | ||
912 | |a GBV_ILN_2065 | ||
912 | |a GBV_ILN_2068 | ||
912 | |a GBV_ILN_2070 | ||
912 | |a GBV_ILN_2086 | ||
912 | |a GBV_ILN_2088 | ||
912 | |a GBV_ILN_2093 | ||
912 | |a GBV_ILN_2106 | ||
912 | |a GBV_ILN_2107 | ||
912 | |a GBV_ILN_2108 | ||
912 | |a GBV_ILN_2110 | ||
912 | |a GBV_ILN_2111 | ||
912 | |a GBV_ILN_2112 | ||
912 | |a GBV_ILN_2113 | ||
912 | |a GBV_ILN_2116 | ||
912 | |a GBV_ILN_2118 | ||
912 | |a GBV_ILN_2119 | ||
912 | |a GBV_ILN_2122 | ||
912 | |a GBV_ILN_2129 | ||
912 | |a GBV_ILN_2131 | ||
912 | |a GBV_ILN_2143 | ||
912 | |a GBV_ILN_2144 | ||
912 | |a GBV_ILN_2147 | ||
912 | |a GBV_ILN_2148 | ||
912 | |a GBV_ILN_2152 | ||
912 | |a GBV_ILN_2153 | ||
912 | |a GBV_ILN_2188 | ||
912 | |a GBV_ILN_2190 | ||
912 | |a GBV_ILN_2232 | ||
912 | |a GBV_ILN_2336 | ||
912 | |a GBV_ILN_2446 | ||
912 | |a GBV_ILN_2470 | ||
912 | |a GBV_ILN_2474 | ||
912 | |a GBV_ILN_2507 | ||
912 | |a GBV_ILN_2522 | ||
912 | |a GBV_ILN_2548 | ||
912 | |a GBV_ILN_4035 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4046 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4242 | ||
912 | |a GBV_ILN_4246 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4251 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4326 | ||
912 | |a GBV_ILN_4333 | ||
912 | |a GBV_ILN_4334 | ||
912 | |a GBV_ILN_4335 | ||
912 | |a GBV_ILN_4336 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4393 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 28 |j 2019 |e 6 |b 16 |c 04 |h 873-883 |